ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,126Medicare Part D Prescriptions Filled, Including Refills

Rank: 275 out of 973

$392K Total Retail Price of All Prescriptions

Rank: 240 out of 973

410 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 214 207 1 2
OMEPRAZOLE 193 187 2 5
FUROSEMIDE 153 152 3 6
POTASSIUM CHLORIDE 150 146 4 9
METFORMIN HCL 142 138 5 8
AMLODIPINE BESYLATE 137 137 6 7
COUMADIN 137 116 6 205
METOPROLOL SUCCINATE 132 131 8 17
SYNTHROID 125 125 9 50
SIMVASTATIN 124 123 10 1
METOPROLOL TARTRATE 122 118 11 13
HYDROCODONE-ACETAMINOPHEN 116 103 S3 12 4
CITALOPRAM HBR 106 106 13 14
SOTALOL 100 100 14 178
DONEPEZIL HCL 95 95 15 26
METHYLPREDNISOLONE 89 89 16 159
SPIRONOLACTONE 87 87 17 49
LOSARTAN POTASSIUM 86 86 18 19
HYDROCHLOROTHIAZIDE 83 81 19 11
ATENOLOL 82 81 20 16
NEXIUM 81 71 21 30
GABAPENTIN 80 78 22 12
PREMARIN 77 70 R 23 116
FLUTICASONE PROPIONATE 77 67 23 35
CARBIDOPA-LEVODOPA 75 75 25 71
LOSARTAN-HYDROCHLOROTHIAZIDE 74 74 26 46
WARFARIN SODIUM 73 69 27 10
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 70 28 76
MELOXICAM 70 70 29 23
ESCITALOPRAM OXALATE 70 69 29 68
LISINOPRIL 65 57 31 3
PREDNISONE 65 64 31 33
SUCRALFATE 64 64 33 131
ALLOPURINOL 61 61 34 29
ISOSORBIDE MONONITRATE ER 61 60 34 85
PANTOPRAZOLE SODIUM 58 52 36 37
MIRTAZAPINE 56 56 37 43
DICLOFENAC SODIUM 53 46 38 108
ATORVASTATIN CALCIUM 53 50 38 15
LANOXIN 52 50 40 261
NAMENDA 51 51 41 31
CYMBALTA 50 46 42 40
POLYETHYLENE GLYCOL 3350 50 44 42 36
CARVEDILOL 50 47 42 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.